BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 32544882)

  • 1. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
    Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
    Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
    Zhang M; Pang HJ; Zhao W; Li YF; Yan LX; Dong ZY; He XF
    BMC Cancer; 2018 May; 18(1):511. PubMed ID: 29720116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
    Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
    Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
    Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
    Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
    Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
    Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A negative correlation between B7-H3 expression and the number of CD8+ T cell infiltration in primary hepatocellular carcinoma tissues].
    Liu T; Huo Y; Li G; Yu G; Luan X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Dec; 30(12):1291-4. PubMed ID: 25481188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence.
    Sun TW; Gao Q; Qiu SJ; Zhou J; Wang XY; Yi Y; Shi JY; Xu YF; Shi YH; Song K; Xiao YS; Fan J
    Cancer Immunol Immunother; 2012 Nov; 61(11):2171-82. PubMed ID: 22729558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the B7-H3 immune checkpoint limits hepatocellular carcinoma progression by enhancing T lymphocyte-mediated immune cytotoxicity in vitro and in vivo.
    Zhou Z; Yu X; Chen Y; Tan X; Liu W; Hua W; Chen L; Zhang W
    Clin Transl Oncol; 2023 Apr; 25(4):1067-1079. PubMed ID: 36512305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
    Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
    Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
    Front Immunol; 2021; 12():612139. PubMed ID: 33679751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new risk model comprising genes highly correlated with CD133 identifies different tumor-immune microenvironment subtypes impacting prognosis in hepatocellular carcinoma.
    Yu H; Zhu X; Lin H; Pan H; Zhao F; Zhu M; Sun L; Chai W; Yao M; Yan M
    Aging (Albany NY); 2020 Jun; 12(12):12234-12250. PubMed ID: 32564007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
    Sia D; Jiao Y; Martinez-Quetglas I; Kuchuk O; Villacorta-Martin C; Castro de Moura M; Putra J; Camprecios G; Bassaganyas L; Akers N; Losic B; Waxman S; Thung SN; Mazzaferro V; Esteller M; Friedman SL; Schwartz M; Villanueva A; Llovet JM
    Gastroenterology; 2017 Sep; 153(3):812-826. PubMed ID: 28624577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
    Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma.
    Ho WJ; Danilova L; Lim SJ; Verma R; Xavier S; Leatherman JM; Sztein MB; Fertig EJ; Wang H; Jaffee E; Yarchoan M
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
    Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
    BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma.
    Chen Y; Wang X; Deng X; Zhang Y; Liao R; Li Y; Yang H; Chen K
    Front Immunol; 2021; 12():676922. PubMed ID: 34335575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression.
    Wang F; Wang G; Liu T; Yu G; Zhang G; Luan X
    Cancer Invest; 2014 Jul; 32(6):262-71. PubMed ID: 24787022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.